Literature DB >> 11445139

Opioid-NMDA receptor interactions may clarify conditioned (associative) components of opioid analgesic tolerance.

A Y Bespalov1, E E Zvartau, P M Beardsley.   

Abstract

Recent evidence suggests that acute administration of opioid analgesic drugs (such as morphine or heroin) produces delayed hyperalgesia. This hyperalgesic response is likely to result from hyperactivation of NMDA receptors triggered by stimulation of opioid receptors and may mediate acute tolerance. In support of this hypothesis, blockade of NMDA receptors attenuates opioid-induced delayed hyperalgesia and prolongs the duration of antinociceptive activity of morphine. Furthermore, the NMDA receptor-induced hyperalgesia is likely an unconditioned response to opioid receptor stimulation that becomes spatiotemporally associated with environmental cues accompanying repeated opioid exposure. This hypothesis conforms to the traditional Pavlovian requirement for conditioned and unconditioned responses to be qualitatively similar. In support of the role of NMDA receptor hyperactivation in morphine tolerance, NMDA receptor antagonists have been shown to block development of analgesic tolerance induced by repeated exposures to morphine. The view of the conditioned nature of opioid tolerance may be significantly extended by assuming that upon repeated drug administration an early-onset effect of a drug may become a predictive stimulus for a later-onset effect and, consequentially, it may become empowered to elicit the later-onset effect itself. Such 'intra-drug' conditioning hypothesis is well in line with the current experimental evidence but further studies will be needed to verify it directly.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445139     DOI: 10.1016/s0149-7634(01)00018-5

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  4 in total

1.  Placebo analgesia affects the behavioral despair tests and hormonal secretions in mice.

Authors:  Jian-You Guo; Xiao-Ying Yuan; Feng Sui; Wen-Cai Zhang; Jin-Yan Wang; Fei Luo; Jing Luo
Journal:  Psychopharmacology (Berl)       Date:  2011-03-30       Impact factor: 4.530

Review 2.  Methadone: a new old drug with promises and pitfalls.

Authors:  Jodie A Trafton; Abhinav Ramani
Journal:  Curr Pain Headache Rep       Date:  2009-02

3.  Comparison of effect of intravenous ketamine, peritonsillar infiltration of tramadol and their combination on pediatric posttonsillectomy pain: A double-blinded randomized placebo-controlled clinical trial.

Authors:  A Honarmand; M Safavi; P Kashefi; B Hosseini; S Badiei
Journal:  Res Pharm Sci       Date:  2013-07

4.  Low-dose intravenous ketamine versus intravenous ketorolac in pain control in patients with acute renal colic in an emergency setting: a double-blind randomized clinical trial.

Authors:  Mehran Sotoodehnia; Mozhgan Farmahini-Farahani; Arash Safaie; Fatemeh Rasooli; Alireza Baratloo
Journal:  Korean J Pain       Date:  2019-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.